Advice You - Business

Many of us have heard the term “down-sizing”. Down-sizing in corporations has taken it’s toll on the American worker. Many people, ranging in age from their late 40s to early

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

60s, are faced with very difficult decisions.

These middle-aged, middle managers are being asked to consider "early retirement." The offers from their employers may range fr

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

m lucrative to paltry, but the decisions are difficult in almost every case. Let's review some of the factors to consider when evaluating one of these "offers you can't refuse

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

."

There are two levels of concern that must be addressed. First, you must consider the emotional aspects of an early retirement decision. It is possible, in fact probable,

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

hat you never considered retiring today. For many people, especially those in their 40s and early 50s, retirement is still a hazy goal, far off in the future. They may not ha

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ve given any thought to what they will do during retirement, whether they will seek other employment or any of a myriad of other questions.

The offer of early retirement can a

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

fect those who choose to stay with the company as well. Will they have the same, hopefully positive, feelings toward their employer and supervisor? Early retirement programs

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

are often instituted by companies undergoing stressful and uncertain times. Staying around may seem almost as difficult as leaving. You may be unable or unwilling to make fin

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ncial decisions until these emotional and psychological issues are confronted.

The other level of concern is financial. Obviously, you have two choices: do I stay, or do I go

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

? If you choose to stay, what is the financial health of the company? Should you take the money and run? If you stay, what are the prospects for career promotions and pay in

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

reases? Will staying merely postpone an inevitable career change, under perhaps less advantageous circumstances? Of course, leaving is also fraught with uncertainty. If you

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ntend to pursue another position, many experts have suggested that your job search will last about one month for every $10,000 in compensation paid by the former employer. Man

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

y early retirees become entrepreneurs, so the prospects for a new business and the need for start-up capital must be considered.

When evaluating the retirement offer itself, t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ere are also a variety of potential pitfalls. Health insurance is a major concern for many, so find out whether you will continue to be covered. Employers with defined benefi

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

t plans may be granting additional years of service or assuming early retirees are older than their actual age for purposes of computing their benefit. The employer may also o

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

fer some additional benefit to tide the employee over until age 62 when they can begin to collect Social Security.

Tax issues also come into play. Numerous special rules may

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

apply. For example, those who were born before 1936 may qualify to use ten-year forward averaging. Those who are 55 or older when they receive their retirement plan distribut

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

on are not subject to the 10% penalty. If you elect to pursue the substantially equal payment exception to the 10% penalty, the payments must continue for the longer of five y

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ears or turning age 59-1/2.

Of course, this brief article is no substitute for a careful consideration of all of the advantages and disadvantages of this matter in light of yo

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

r unique personal circumstances. Before implementing any significant tax or financial planning strategy, contact your financial planner, attorney or tax advisor as appropriate

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/12060/adviceyou-An-Offer-You-Cant-Refuse.html">An Offer You Can't Refuse</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/12060/adviceyou-An-Offer-You-Cant-Refuse.html]An Offer You Can't Refuse[/url]

What do you need to be doing to succeed in life? What traps await you on your path? How much are goals really important? Is it true ...

There has never been a speedier method or a method that gets the word out to others better than simply word of mouth. People love to chat with one another. They really enjoy being able to be the first to share new information to someone.

With Internet use spreading across the globe, one advertising message no longer fits all. Believe it or not, Asians, Europeans and Latin Americans account for more than 60 percent of all Web traffic, and the percentage is climbing. At the same time, Internet shoppers everywhere are becoming increasingly hostile to generic pop-ups and banners. So, how can on-line advertisers get results in such a complex and demanding marketplace? A big part of the answer is geo-targeting.

Tags

Links

Advice You - An Offer You Can't Refuse

Related Articles: